Concepedia

J. R. Jett

JR

3

Publications

105

Citations

3

H-Index

1997

Active since

Affiliations

University of Kansas Medical Center(Current)

J. R. Jett is an author at University of Kansas Medical Center specializing in oncology, cancer therapeutics, and lung cancer.

Top concepts

MedicineOncologyLung CancerCancer TherapyMolecular OncologyRadiation OncologyHealthPathologyClinical TrialsRadiotherapy

Publications per year

1997–2008

3

Publications

3

S0124: A randomized phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated extensive stage small cell lung cancer (E-SCLC)

Ronald B. Natale, Primo N. Lara, Kari Chansky et al. · Journal of Clinical Oncology · 2008 · 44 citations

Genetic Epidemiology, Human Polymorphism, Pathology +18

Updated analysis of SWOG 0023: A randomized phase III trial of gefitinib versus placebo maintenance after definitive chemoradiation followed by docetaxel in patients with locally advanced stage III non-small cell lung cancer

Karen Kelly, Kari Chansky, Laurie E. Gaspar et al. · Journal of Clinical Oncology · 2007 · 40 citations

Pharmacotherapy, Swog 0023, Pre-clinical Pharmacology +18

38 Topotecan and paclitaxel in extensive stage small cell lung cancer (ED-SCLC) patients without prior therapy

J. R. Jett, R. Day, Mark L. Levitt et al. · Lung Cancer · 1997 · 21 citations

Prior Therapy, Medicine, Pathology +7

Rows per page

1–3 of 3